Skip To Content
JEWISH. INDEPENDENT. NONPROFIT.
Breaking News

New York Teen Makes Cancer Discovery — on Own Illness

At 12 years old, Elana Simon was diagnosed with fibrolamellar hepatocellular carcinoma, a rare form of liver cancer that largely affects adolescents and young adults.

“I didn’t know much about [fibrolamellar] and it was pretty scary,” said Simon, now 19. “But I was extremely fortunate to have an incredible surgeon.”

After having her tumor removed, Simon, who grew up in New York, where her family remains active members of Temple Shaaray Tefila on Manhattan’s Upper East Side, has been “totally fine ever since.” Currently a freshman at Harvard University, Simon is majoring in computer science.

During her sophomore year of high school, while interning at a lab working on cancer research, she had the idea to genetically sequence fibrolamellar.

Simon sought the advice of her former surgeon, Dr. Michael LaQuaglia, chief of the pediatric surgical service at Memorial Sloan Kettering Cancer Center, and learned that due to the rarity of the disease, not much research had been done.

“Just because no one had done this before didn’t mean it couldn’t be done,” Simon said. “And as someone who had this type of cancer, who better than a patient with a specific interest in this disease?”

Her father, Sandy, a biophysicist, made space in his lab at Rockefeller University, and Simon set about collecting tumor samples from other fibrolamellar patients and survivors.

Fifteen samples were ultimately sequenced by a team at the New York Genome Center. Back at the Rockefeller lab, Simon and her collaborators discovered that all the samples shared the same genetic mutation.

“We were lucky that we found something weird and different,” Simon said of the discovery. While additional research is still needed, she said, interest in the disease has piqued and could lead to improved diagnostic testing and drug treatments.

In February, Simon co-authored a study, published in Science magazine, about the discovered genetic mutation.

Of the research, she said, “I kept asking why. I was willing to ask questions, and we were able to try something different and it was successful.”

JTA spoke recently to Simon about her heroes, her favorite Jewish food and what she hopes to do professionally in a few years.

JTA: What do you think are the important qualities of a hero?

Simon: I think it’s important for a hero to be both brave and determined. A hero needs to care about something, and be bold and willing to work towards their goal.

Who are your heroes?

My father and my surgeon. They are the smartest people I know and dedicate their lives to helping others unconditionally. They are humble and work as hard as they can.

Can you share with us a meaningful Jewish experience that you’ve had?

A meaningful Jewish experience for me was my involvement with Camp Simcha. This is a Jewish camp for young cancer survivors and patients, and it was one of the most fun and uplifting places I’ve ever been to. It was beautiful to see how much joy and hope everyone had, and to see how much strength people derived from their religion.

Do you have a favorite Jewish food?

I do have an addiction to egg challah.

What kind of things do you like to do for fun?

I like performing. I sing, dance and act, do theater and acrobatics. I play with my dog and hang out with my friends.

What do you think you want to do professionally in a few years?

I’m not sure, but I am definitely interested in studying computer science. It’s a powerful tool. Whether it’s doing research using computer science to study diseases or whatever I do, I want to help people

A message from our CEO & publisher Rachel Fishman Feddersen

I hope you appreciated this article. Before you go, I’d like to ask you to please support the Forward’s award-winning, nonprofit journalism during this critical time.

We’ve set a goal to raise $260,000 by December 31. That’s an ambitious goal, but one that will give us the resources we need to invest in the high quality news, opinion, analysis and cultural coverage that isn’t available anywhere else.

If you feel inspired to make an impact, now is the time to give something back. Join us as a member at your most generous level.

—  Rachel Fishman Feddersen, Publisher and CEO

With your support, we’ll be ready for whatever 2025 brings.

Republish This Story

Please read before republishing

We’re happy to make this story available to republish for free, unless it originated with JTA, Haaretz or another publication (as indicated on the article) and as long as you follow our guidelines. You must credit the Forward, retain our pixel and preserve our canonical link in Google search.  See our full guidelines for more information, and this guide for detail about canonical URLs.

To republish, copy the HTML by clicking on the yellow button to the right; it includes our tracking pixel, all paragraph styles and hyperlinks, the author byline and credit to the Forward. It does not include images; to avoid copyright violations, you must add them manually, following our guidelines. Please email us at editorial@forward.com, subject line “republish,” with any questions or to let us know what stories you’re picking up.

We don't support Internet Explorer

Please use Chrome, Safari, Firefox, or Edge to view this site.

Exit mobile version